GlassScriptPhysician profile
Kevin A Hallman
NPI 1437142924
$4,495.61
in general payments reported to CMS, 2019-2025
28 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $197 · 2021: $336 · 2022: $714 · 2023: $2,264 · 2024: $438 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050 · Travel and Lodging: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.73 |
| Travel and Lodging | $1,002.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,161.51 | 2021-2024 | Axonics, Bulkamid |
| Coopersurgical, INC. | $400.17 | 2020-2023 | Advincula Delineator Uterine Manipulator, Mara Console, Paragard T 380a |
| Caldera Medical, INC | $338.39 | 2021-2025 | Desara |
| Boston Scientific Corporation | $292.99 | 2019-2025 | Axonics, Advantage System, Upsylon |
| Cytyc Surgical Products, LLC | $144.12 | 2023 | Acessa Provu System |
| Pacira Pharmaceuticals Incorporated | $124.92 | 2021 | |
| Dilon Technologies, INC. | $114.38 | 2025 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $87.97 | 2022 | |
| Ethicon US, LLC | $78.06 | 2019-2020 | |
| Therapeuticsmd, INC. | $74.70 | 2019-2021 | |
| Organon LLC | $68.46 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $68.35 | 2019-2023 | Veozah |
| Daiichi Sankyo INC. | $65.25 | 2019-2022 | |
| Myriad Women'S Health, INC. | $62.66 | 2023 | |
| Coloplast Corp | $59.08 | 2019-2023 | Saffron, Altis |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monaghan Medical Corporation | $47.44 | 2023 | Aeroeclipse |
| Applied Medical Resources Corporation | $43.47 | 2023 | |
| Roche Diagnostics Corporation | $42.46 | 2019 | |
| Northgate Technologies, INC. | $35.11 | 2023 | Stimsite (Nti) |
| Gynesonics, INC. | $30.93 | 2022 | |
| Sage Therapeutics, LLC | $30.84 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $26.48 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $21.97 | 2023 | Aptima |
| Amgen INC. | $20.67 | 2023 | Prolia, Evenity |
| Supernus Pharmaceuticals, INC. | $15.66 | 2025 | Qelbree |
| Novo Nordisk INC | $13.52 | 2025 | Wegovy |
| Abbvie INC. | $13.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hallman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.